Company: HCTI
Filing Date: 2025-11-17
Form Type: DEF 14A
Source: 0001213900-25-111526
Chunk: 9

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-17
Form: DEF 14A
Chunk 9
---
 at our special meeting will be available at our special meeting and, for 10 days prior to our special meeting, at Healthcare 
 Triangle, Inc., 7901 Stoneridge Drive, Suite 220, Pleasanton, California 94588. Telephone: (925) 270-4812.                           |

| Q. | Who should I contact if I have any questions 
 about how to vote?                           |

| A. | If you have any questions about how to vote your shares, 
 you may contact Alliance Advisors at (866) 804-9616.     |

<div align='center'>4

NASDAQ APPROVAL PROPOSAL</div>

TO CONSIDER AND VOTE ON A PROPOSAL TO APPROVE, FOR PURPOSES OF NASDAQ LISTING RULE 5635(D), ISSUNCES OF SECURITIES THAT ARE COMPLETED FROM NOVEMBER 14, 2025 UNTIL FEBRUARY 28, 2026 THAT ARE IN THE AGGREGATE UP TO $70 MILLION, AS LONG AS EACH FUTURE ISSUNACE IS WITHIN THE NASDAQ PARAMETERS (AS DEFINED BELOW).

Our stockholders are being asked to approve at the Special Meeting,
for purposes of Nasdaq Listing Rule 5635(d), issuances of the Company’s securities that are completed from and after November 14,
2025 until February 28, 2026r that are in the aggregate up to $70 million (“Future Issuances”), as long as each Future Issuance
is within the Nasdaq Parameters (as defined below).

Pursuant to Nasdaq Listing Rule 5635(d),
stockholder approval is required prior to a 20% Issuance at a price that is less than the Minimum Price. For purposes of Nasdaq Listing
Rule 5635(d), (i) “20% Issuance” means a transaction, other than a public offering, involving the sale, issuance
or potential issuance by us of common stock (or securities convertible into or exercisable for common stock), which alone or together
with sales by our officers, directors or substantial stockholders equals 20% or more of common stock or 20% or more of the voting power
outstanding before the issuance, and (ii)“Minimum Price” means a price that is the lower of: (A) the closing price
(as reflected on NASDAQ.com) immediately preceding the signing of the binding agreement; or (B) the average closing price of